Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunction(R)-limonene 6-monooxygenase activity

CYP2C19 CYP2C9

8.29e-062582GO:0052741
GeneOntologyMolecularFunctionlimonene monooxygenase activity

CYP2C19 CYP2C9

8.29e-062582GO:0019113
GeneOntologyMolecularFunction(S)-limonene 6-monooxygenase activity

CYP2C19 CYP2C9

8.29e-062582GO:0018675
GeneOntologyMolecularFunction(S)-limonene 7-monooxygenase activity

CYP2C19 CYP2C9

8.29e-062582GO:0018676
GeneOntologyMolecularFunctionlinoleic acid epoxygenase activity

CYP2C19 CYP2C9

4.96e-054582GO:0071614
GeneOntologyMolecularFunctionarachidonate 11,12-epoxygenase activity

CYP2C19 CYP2C9

4.96e-054582GO:0008405
GeneOntologyMolecularFunctionfatty acid omega-1 hydroxylase activity

CYP2C19 CYP2C9

8.25e-055582GO:0120502
GeneOntologyMolecularFunctionlong-chain fatty acid omega-1 hydroxylase activity

CYP2C19 CYP2C9

8.25e-055582GO:0120319
GeneOntologyMolecularFunctionarachidonate 14,15-epoxygenase activity

CYP2C19 CYP2C9

8.25e-055582GO:0008404
GeneOntologyMolecularFunctionoxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor

CYP2C19 CYP2C9

2.30e-048582GO:0033695
GeneOntologyMolecularFunctioncaffeine oxidase activity

CYP2C19 CYP2C9

2.30e-048582GO:0034875
GeneOntologyMolecularFunctionestrogen 16-alpha-hydroxylase activity

CYP2C19 CYP2C9

4.48e-0411582GO:0101020
GeneOntologyMolecularFunctionretinoic acid 4-hydroxylase activity

CYP2C19 CYP2C9

7.38e-0414582GO:0008401
GeneOntologyMolecularFunctionoxidoreductase activity, acting on CH or CH2 groups

CYP2C19 CYP2C9

8.50e-0415582GO:0016725
GeneOntologyMolecularFunctiontetrapyrrole binding

CYP2C19 CYP2C9 NOX3 CUBN

1.32e-03164584GO:0046906
GeneOntologyMolecularFunctionarachidonate epoxygenase activity

CYP2C19 CYP2C9

2.20e-0324582GO:0008392
GeneOntologyMolecularFunctioncullin family protein binding

KLHL21 KLHL13

2.58e-0326582GO:0097602
GeneOntologyMolecularFunctionarachidonate monooxygenase activity

CYP2C19 CYP2C9

2.78e-0327582GO:0008391
GeneOntologyMolecularFunctionsteroid hydroxylase activity

CYP2C19 CYP2C9

4.38e-0334582GO:0008395
GeneOntologyMolecularFunctionaromatase activity

CYP2C19 CYP2C9

4.64e-0335582GO:0070330
GeneOntologyCellularComponentreceptor complex

TLR4 KDR CUBN GABBR2 NOTCH1 CHRNB1 SHISA6 SHISA8

1.91e-04581588GO:0043235
DomainShisa

SHISA6 SHISA8

3.02e-049552PF13908
DomainShisa

SHISA6 SHISA8

3.02e-049552IPR026910
DomainEGF

ZAN CUBN F12 NOTCH1

5.16e-04126554PF00008
DomainTIL

ZAN OTOG

5.51e-0412552PF01826
DomainC8

ZAN OTOG

5.51e-0412552PF08742
DomainEGF_3

ZAN CUBN F12 NOTCH1 OTOG

6.30e-04235555PS50026
DomainUnchr_dom_Cys-rich

ZAN OTOG

6.50e-0413552IPR014853
DomainC8

ZAN OTOG

6.50e-0413552SM00832
DomainKelch

KLHL21 KLHL13 KLHDC7B

6.65e-0458553SM00612
DomainGal_Oxase/kelch_b-propeller

KLHL21 KLHL13 KLHDC7B

6.99e-0459553IPR011043
DomainTIL_dom

ZAN OTOG

7.57e-0414552IPR002919
DomainEGF-like_dom

ZAN CUBN F12 NOTCH1 OTOG

8.17e-04249555IPR000742
DomainVWD

ZAN OTOG

9.95e-0416552SM00216
DomainVWF_type-D

ZAN OTOG

9.95e-0416552IPR001846
DomainVWFD

ZAN OTOG

9.95e-0416552PS51233
DomainVWD

ZAN OTOG

9.95e-0416552PF00094
DomainKelch_1

KLHL21 KLHL13 KLHDC7B

1.15e-0370553PF01344
DomainKelch_1

KLHL21 KLHL13 KLHDC7B

1.15e-0370553IPR006652
DomainVWC_out

ZAN OTOG

1.41e-0319552SM00215
DomainApc4_WD40_dom

WDHD1 EML6

1.56e-0320552IPR024977
DomainANAPC4_WD40

WDHD1 EML6

1.56e-0320552PF12894
Domain-

KLHL21 KLHL13

2.85e-03275522.130.10.80
DomainGal_Oxidase_b-propeller

KLHL21 KLHL13

4.50e-0334552IPR015916
DomainEGF

ZAN CUBN F12 NOTCH1

5.04e-03235554SM00181
DomainEGF_CA

CUBN F12 NOTCH1

5.57e-03122553SM00179
DomainEGF-like_Ca-bd_dom

CUBN F12 NOTCH1

5.83e-03124553IPR001881
DomainEGF_1

ZAN CUBN F12 NOTCH1

6.71e-03255554PS00022
DomainVWF_dom

ZAN OTOG

6.80e-0342552IPR001007
DomainBTB-kelch_protein

KLHL21 KLHL13

7.12e-0343552IPR017096
DomainEGF-like_CS

ZAN CUBN F12 NOTCH1

7.27e-03261554IPR013032
DomainEGF_2

ZAN CUBN F12 NOTCH1

7.67e-03265554PS01186
DomainCyt_P450_E_grp-I

CYP2C19 CYP2C9

7.77e-0345552IPR002401
DomainCUB

CUBN ADGRG6

9.16e-0349552PF00431
Pubmed

Hedgehog regulates distinct vascular patterning events through VEGF-dependent and -independent mechanisms.

GLI1 KDR NOTCH1

5.24e-071058320339091
Pubmed

Important amino acid residues that confer CYP2C19 selective activity to CYP2C9.

CYP2C19 CYP2C9

2.73e-06258218511451
Pubmed

Developmental expression of human hepatic CYP2C9 and CYP2C19.

CYP2C19 CYP2C9

2.73e-06258214634042
Pubmed

CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract.

CYP2C19 CYP2C9

2.73e-06258210908295
Pubmed

GPR126 protein regulates developmental and pathological angiogenesis through modulation of VEGFR2 receptor signaling.

KDR ADGRG6

2.73e-06258225217645
Pubmed

Oxygenation mechanism in conversion of aldehyde to carboxylic acid catalyzed by a cytochrome P-450 isozyme.

CYP2C19 CYP2C9

2.73e-0625821847130
Pubmed

Cytochromes P450 catalyze oxidation of alpha,beta-unsaturated aldehydes.

CYP2C19 CYP2C9

2.73e-06258217599801
Pubmed

Dosage recommendation of phenytoin for patients with epilepsy with different CYP2C9/CYP2C19 polymorphisms.

CYP2C19 CYP2C9

2.73e-06258215385837
Pubmed

[Effect of original and generic clopidogrel on prognosis in relation to different gene polymorphisms].

CYP2C19 CYP2C9

2.73e-06258225518510
Pubmed

Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism.

CYP2C19 CYP2C9

2.73e-06258215842554
Pubmed

Rapid identification of the hepatic cytochrome P450 2C19 activity using a novel and noninvasive [13C]pantoprazole breath test.

CYP2C19 CYP2C9

2.73e-06258219136640
Pubmed

Mouse Cyp2c expression and zonation structure in the liver begins in the early neonatal stage.

CYP2C19 CYP2C9

2.73e-06258235748067
Pubmed

Time serial transcriptome reveals Cyp2c29 as a key gene in hepatocellular carcinoma development.

CYP2C19 CYP2C9

2.73e-06258232587777
Pubmed

Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population.

CYP2C19 CYP2C9

2.73e-06258217201743
Pubmed

CYP2C9 (*2&*3) and CYP2C19 (*2&*3) polymorphisms among children with nonlesional epilepsy: a single-center study.

CYP2C19 CYP2C9

2.73e-06258232683556
Pubmed

Evaluation of phenytoin dosage regimens based on genotyping of CYP2C subfamily in routinely treated Japanese patients.

CYP2C19 CYP2C9

2.73e-06258215855721
Pubmed

The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects.

CYP2C19 CYP2C9

2.73e-06258219847408
Pubmed

CYP2C9 and CYP2C19 polymorphic forms are related to increased indisulam exposure and higher risk of severe hematologic toxicity.

CYP2C19 CYP2C9

2.73e-06258217504998
Pubmed

Cytochrome P450 2C epoxygenases mediate photochemical stress-induced death of photoreceptors.

CYP2C19 CYP2C9

2.73e-06258224519941
Pubmed

Mouse liver CYP2C39 is a novel retinoic acid 4-hydroxylase. Its down-regulation offers a molecular basis for liver retinoid accumulation and fibrosis in aryl hydrocarbon receptor-null mice.

CYP2C19 CYP2C9

2.73e-06258214623888
Pubmed

An Endothelial Hsp70-TLR4 Axis Limits Nox3 Expression and Protects Against Oxidant Injury in Lungs.

TLR4 NOX3

2.73e-06258226905942
Pubmed

The Frequency of the Minor Polymorphisms in the CYP2C19, VEGFR-2 Genes, and Clinical Outcomes in Russian and Buryat Patients with Acute Coronary Syndrome.

CYP2C19 KDR

2.73e-06258232392440
Pubmed

Rapid testing of clopidogrel resistance by genotyping of CYP2C19 and CYP2C9 polymorphisms using denaturing on-chip capillary electrophoresis.

CYP2C19 CYP2C9

2.73e-06258222589111
Pubmed

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

CYP2C19 CYP2C9

2.73e-06258215660966
Pubmed

Association of galactose single-point test levels and phenytoin metabolic polymorphisms with gingival hyperplasia in patients receiving long-term phenytoin therapy.

CYP2C19 CYP2C9

2.73e-06258218154472
Pubmed

Impact of age, gender and CYP2C9/2C19 genotypes on dose-adjusted steady-state serum concentrations of valproic acid-a large-scale study based on naturalistic therapeutic drug monitoring data.

CYP2C19 CYP2C9

2.73e-06258227353638
Pubmed

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects.

CYP2C19 CYP2C9

2.73e-06258217298483
Pubmed

Analysis of the Potential Association of Drug-Metabolizing Enzymes CYP2C9*3 and CYP2C19*3 Gene Variations With Type 2 Diabetes: A Case-Control Study.

CYP2C19 CYP2C9

2.73e-06258233115391
Pubmed

Contributions of CYP2C9/CYP2C19 genotypes and drug interaction to the phenytoin treatment in the Korean epileptic patients in the clinical setting.

CYP2C19 CYP2C9

2.73e-06258217562299
Pubmed

Prevalence of CYP2C9 and CYP2C19 variants and the impact on clopidogrel efficacy in patients having CYPC19*2 variant.

CYP2C19 CYP2C9

2.73e-06258236960518
Pubmed

Characterization of drug-metabolizing enzymes CYP2C9, CYP2C19 polymorphisms in Tunisian, Kuwaiti and Bahraini populations.

CYP2C19 CYP2C9

2.73e-06258226690534
Pubmed

Covariate-based dose individualization of the cytotoxic drug indisulam to reduce the risk of severe myelosuppression.

CYP2C19 CYP2C9

2.73e-06258219199010
Pubmed

A comparative analysis of binding sites between mouse CYP2C38 and CYP2C39 based on homology modeling, molecular dynamics simulation and docking studies.

CYP2C19 CYP2C9

2.73e-06258219358898
Pubmed

Cyp2c-deficiency depletes muricholic acids and protects against high-fat diet-induced obesity in male mice but promotes liver damage.

CYP2C19 CYP2C9

2.73e-06258234438105
Pubmed

Chromosomal organization of the cytochrome P450-2C gene family in the mouse: a locus associated with constitutive aryl hydrocarbon hydroxylase.

CYP2C19 CYP2C9

2.73e-0625822895926
Pubmed

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics and pharmacodynamics of gliclazide in healthy Chinese Han volunteers.

CYP2C19 CYP2C9

2.73e-06258220831536
Pubmed

CYP2C9, but not CYP2C19, polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects.

CYP2C19 CYP2C9

2.73e-06258216198656
Pubmed

An endothelial TLR4-VEGFR2 pathway mediates lung protection against oxidant-induced injury.

TLR4 KDR

2.73e-06258226655705
Pubmed

[Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration].

CYP2C19 CYP2C9

2.73e-06258215569425
Pubmed

An association between the rs1799853 and rs1057910 polymorphisms of CYP2C9, the rs4244285 polymorphism of CYP2C19 and the prevalence rates of drug-resistant epilepsy in children.

CYP2C19 CYP2C9

2.73e-06258232567426
Pubmed

Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis.

CYP2C19 CYP2C9

2.73e-06258217868191
Pubmed

Impact of CYP2C19 and CYP2C9 gene polymorphisms on sodium valproate plasma concentration in patients with epilepsy.

CYP2C19 CYP2C9

2.73e-06258232868386
Pubmed

CYP2C9 and CYP2C19 Allele and Haplotype Distributions in Four Mestizo Populations from Western Mexico: An Interethnic Comparative Study.

CYP2C19 CYP2C9

2.73e-06258227617498
Pubmed

Influence of the CYP2C9 AND CYP2C19 polymorphisms on phenytoin hydroxylation in healthy individuals from south India.

CYP2C19 CYP2C9

2.73e-06258216873909
Pubmed

Comparison of the in vitro mutagenicity and metabolism of dimethylnitrosamine and benzo[a]pyrene in tissues from inbred mice treated with phenobarbital, 3-methylcholanthrene or polychlorinated biphenyls.

CYP2C19 CYP2C9

2.73e-062582106274
Pubmed

Cross-talk between the Toll-like receptor 4 and Notch1 pathways augments the inflammatory response in the interstitial cells of stenotic human aortic valves.

TLR4 NOTCH1

2.73e-06258222965987
Pubmed

Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study.

CYP2C19 CYP2C9

2.73e-06258215776277
Pubmed

Effect of cytochrome P450 2C19 and 2C9 amino acid residues 72 and 241 on metabolism of tricyclic antidepressant drugs.

CYP2C19 CYP2C9

2.73e-06258224492587
Pubmed

Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days.

CYP2C19 CYP2C9

2.73e-06258216232205
Pubmed

Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China.

CYP2C19 CYP2C9

2.73e-06258220845310
Pubmed

Crosstalk between TLR4 and Notch1 signaling in the IgA nephropathy during inflammatory response.

TLR4 NOTCH1

2.73e-06258229230705
Pubmed

Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid.

CYP2C19 CYP2C9

2.73e-0625829721182
Pubmed

Cytochrome P450 polymorphisms in patients with Behcet's disease.

CYP2C19 CYP2C9

2.73e-06258217269966
Pubmed

Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes.

CYP2C19 CYP2C9

2.73e-06258211950794
Pubmed

Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI).

CYP2C19 CYP2C9

2.73e-06258217279092
Pubmed

Associations of CYP2C9 and CYP2C19 Pharmacogenetic Variation with Phenytoin-Induced Cutaneous Adverse Drug Reactions.

CYP2C19 CYP2C9

2.73e-06258232216088
Pubmed

cDNA cloning and sequence of CYP2C29 encoding P-450 MUT-2, a microsomal aldehyde oxygenase.

CYP2C19 CYP2C9

2.73e-0625828130255
Pubmed

Membrane integration of recombinant human P450 forms.

CYP2C19 CYP2C9

2.73e-06258219534586
Pubmed

Inter-phenotypic differences in CYP2C9 and CYP2C19 metabolism: Bayesian meta-regression of human population variability in kinetics and application in chemical risk assessment.

CYP2C19 CYP2C9

2.73e-06258233232775
Pubmed

Population estimation of the effects of cytochrome P450 2C9 and 2C19 polymorphisms on phenobarbital clearance in Japanese.

CYP2C19 CYP2C9

2.73e-06258217304159
Pubmed

Genetic Polymorphisms of CYP2C9/CYP2C19 in Chronic Obstructive Pulmonary Disease.

CYP2C19 CYP2C9

2.73e-06258232757668
Pubmed

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on phenytoin-induced neurological toxicity in Indian epileptic patients.

CYP2C19 CYP2C9

2.73e-06258220390258
Pubmed

Effects of genetic variation at the CYP2C19/CYP2C9 locus on pharmacokinetics of chlorcycloguanil in adult Gambians.

CYP2C19 CYP2C9

2.73e-06258219761366
Pubmed

Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations.

CYP2C19 CYP2C9

2.73e-06258214616425
Pubmed

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance.

CYP2C19 CYP2C9

2.73e-06258212496751
Pubmed

Voriconazole metabolism, toxicity, and the effect of cytochrome P450 2C19 genotype.

CYP2C19 CYP2C9

2.73e-06258224403552
Pubmed

Typing recombinant inbred mouse strains for microsatellite markers on chromosomes 10, 16, 18, 19, and X.

CYP2C19 CYP2C9 GLI1

4.92e-06205838589516
Pubmed

Investigation of allele and genotype frequencies of CYP2C9, CYP2C19 and VKORC1 in Iran.

CYP2C19 CYP2C9

8.19e-06358220885015
Pubmed

Association of genetic polymorphisms with warfarin dose requirements in Chinese patients.

CYP2C19 CYP2C9

8.19e-06358223941071
Pubmed

Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphisms.

CYP2C19 CYP2C9

8.19e-06358217827141
Pubmed

Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19.

CYP2C19 CYP2C9

8.19e-06358223834474
Pubmed

Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine.

CYP2C19 CYP2C9

8.19e-06358216236141
Pubmed

The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels.

CYP2C19 CYP2C9

8.19e-06358211908757
Pubmed

VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients.

CYP2C19 CYP2C9

8.19e-06358216890578
Pubmed

CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis: A GeT-RM Collaborative Project.

CYP2C19 CYP2C9

8.19e-06358235134542
Pubmed

Characterization of a mouse beta 1-adrenergic receptor genomic clone.

CYP2C19 CYP2C9

8.19e-0635828392347
Pubmed

How common are drug and gene interactions? Prevalence in a sample of 1143 patients with CYP2C9, CYP2C19 and CYP2D6 genotyping.

CYP2C19 CYP2C9

8.19e-06358224798722
Pubmed

Delta-like ligand 4 regulates vascular endothelial growth factor receptor 2-driven luteal angiogenesis through induction of a tip/stalk phenotype in proliferating endothelial cells.

KDR NOTCH1

8.19e-06358224074756
Pubmed

Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole.

CYP2C19 CYP2C9

8.19e-06358225241292
Pubmed

Neurological toxicity after phenytoin infusion in a pediatric patient with epilepsy: influence of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms.

CYP2C19 CYP2C9

8.19e-06358222641027
Pubmed

Distribution of CYP2C polymorphisms in an Amerindian population of Brazil.

CYP2C19 CYP2C9

8.19e-06358221977947
Pubmed

Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase.

CYP2C19 CYP2C9

8.19e-06358231128914
Pubmed

Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.

CYP2C19 CYP2C9

8.19e-06358215177309
Pubmed

The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: a cross-sectional study in Iran.

CYP2C19 CYP2C9

8.19e-06358220637959
Pubmed

Cytochrome p450 polymorphisms in geriatric patients: impact on adverse drug reactions--a pilot study.

CYP2C19 CYP2C9

8.19e-06358215813658
Pubmed

CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.

CYP2C19 CYP2C9

8.19e-06358218240905
Pubmed

The effect of genetic polymorphisms of cytochrome P450 CYP2C9, CYP2C19, and CYP2D6 on drug-resistant epilepsy in Turkish children.

CYP2C19 CYP2C9

8.19e-06358224338437
Pubmed

Role of CYP epoxygenases in A2A AR-mediated relaxation using A2A AR-null and wild-type mice.

CYP2C19 CYP2C9

8.19e-06358218805895
Pubmed

Structural characterization of human cytochrome P450 2C19: active site differences between P450s 2C8, 2C9, and 2C19.

CYP2C19 CYP2C9

8.19e-06358223118231
Pubmed

Polymorphisms of CYP2C8, CYP2C9 and CYP2C19 and risk of coronary heart disease in Russian population.

CYP2C19 CYP2C9

8.19e-06358228687336
Pubmed

CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population.

CYP2C19 CYP2C9

8.19e-06358216220110
Pubmed

Cytochrome p450 genotyping by multiplexed real-time dna sequencing with pyrosequencing technology.

CYP2C19 CYP2C9

8.19e-06358215090156
Pubmed

Polymorphic drug metabolizing CYP-enzymes--a pathogenic factor in oral lichen planus?

CYP2C19 CYP2C9

8.19e-06358219192051
Pubmed

CYP2C29 produces superoxide in response to shear stress.

CYP2C19 CYP2C9

8.19e-06358222708815
Pubmed

GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray.

GLI1 NOTCH1

8.19e-06358225667444
Pubmed

A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24.

CYP2C19 CYP2C9

8.19e-0635828530044
Pubmed

Lack of association between genetic polymorphisms of CYP3A4, CYP2C9 and CYP2C19 and antituberculosis drug-induced liver injury in a community-based Chinese population.

CYP2C19 CYP2C9

8.19e-06358223469989
Pubmed

Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.

CYP2C19 CYP2C9

8.19e-06358221173785
Pubmed

Suppression of hepatic ChREBP⍺-CYP2C50 axis-driven fatty acid oxidation sensitizes mice to diet-induced MASLD/MASH.

CYP2C19 CYP2C9

8.19e-06358238740087
Pubmed

Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus.

CYP2C19 CYP2C9

8.19e-06358221108610
InteractionCD93 interactions

ORC4 TENT5A BAG4 F12

7.32e-0645564int:CD93
Cytoband10q24

CYP2C19 CYP2C9

9.09e-043558210q24
Cytoband3q22.1

DNAJC13 TOPBP1

1.31e-03425823q22.1
CytobandEnsembl 112 genes in cytogenetic band chr10q23

CYP2C19 CYP2C9 RNLS

1.96e-03195583chr10q23
GeneFamilyShisa family members

SHISA6 SHISA8

1.19e-048382742
GeneFamilyCytochrome P450 family 2

CYP2C19 CYP2C9

2.45e-03353821001
GeneFamilyKelch like|BTB domain containing

KLHL21 KLHL13

3.51e-0342382617
CoexpressionAtlasProgenitor-Cell-Biology-Consortium_reference_CardioEndothel_top-relative-expression-ranked_1000

THSD7A TLR4 DIPK1B KDR TRIM34 CUBN GABBR2 DYSF ABCA9 AFAP1L1 ADGRG6

2.41e-059785311PCBC_ctl_CardioEndothel_1000
CoexpressionAtlasProgenitor-Cell-Biology-Consortium_reference_CardioEndothel_top-relative-expression-ranked_500

THSD7A TLR4 KDR CUBN GABBR2 DYSF ABCA9 AFAP1L1

2.91e-05495538PCBC_ctl_CardioEndothel_500
ToppCell3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD7A DIPK1B KDR DYSF NOTCH1 AFAP1L1

1.37e-071825860346f81bbb1f309f3e9d063b20547d548d09472c
ToppCell3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD7A DIPK1B KDR DYSF NOTCH1 AFAP1L1

1.61e-0718758625efb82afe863a853ecdd781ad89026c993aaa67
ToppCell5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD7A DIPK1B KDR DYSF NOTCH1 AFAP1L1

1.71e-07189586db09d591b885ce2bc9e353f08b6694e2192582e1
ToppCell3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD7A DIPK1B KDR DYSF AFAP1L1 ADGRG6

2.32e-071995860d63da0afa93741c37609d879941de202d9ac86c
ToppCell5'-GW_trimst-2-LargeIntestine-Endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD7A DIPK1B KDR DYSF NOTCH1 AFAP1L1

2.32e-07199586f0bf75bfae7b288ecb6801be458b03ebd0108ea7
ToppCell5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TLR4 ZSWIM2 KDR DYSF AFAP1L1

3.95e-0618258563b41b538b26bc899558807fd035e543611f8c52
ToppCell5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ZAN DIPK1B KDR DYSF ADGRG6

3.95e-06182585d0e3663f7d39f22a3ebd7fde56ab3504773598f4
ToppCell3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TLR4 DIPK1B KDR DYSF AFAP1L1

4.06e-0618358552af3c943116073c8ddd207b664342960b88929b
ToppCell3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DIPK1B KDR DYSF AFAP1L1 ADGRG6

4.28e-061855850ab1be455f2cd883c9d1522ca78112c37833352e
ToppCell5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DIPK1B KDR DYSF NOTCH1 ADGRG6

4.39e-06186585055cc23c4db9aad2d6c62e62c8e58bfe5047c6b1
ToppCell3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TLR4 DIPK1B KDR DYSF AFAP1L1

4.75e-06189585b5fa3a619e3b554a1a45a551c9b6369075fe5615
ToppCell5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD7A DIPK1B KDR DYSF AFAP1L1

5.12e-061925855a0615fdc217554ccd611504b16e5d97628e207d
ToppCell3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD7A DIPK1B KDR DYSF AFAP1L1

5.12e-061925851f35efb0765e05f7f9c881849953bef3965be25a
ToppCellPCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

DIPK1B KDR DYSF NOTCH1 AFAP1L1

5.25e-06193585643f992dbce639e7d147924d8b8f455fcebf215a
ToppCell3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TLR4 DIPK1B KDR DYSF ADGRG6

5.52e-06195585752a100297c26732e12bbbf3ab27a2bd4f5ea06d
ToppCell5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD7A DIPK1B KDR NOTCH1 AFAP1L1

5.66e-06196585ae46d4b00be92e64e46252dcc156161b171eded4
ToppCellPCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

DIPK1B KDR DYSF NOTCH1 AFAP1L1

5.66e-06196585b826dce5b3daa8eb3d4a530b9564de58d9ce3767
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TLR4 KDR DYSF NOTCH1 AFAP1L1

5.66e-0619658565d882c6e7f6d5778b8a5fd4fdaf012e1b9f6100
ToppCellFetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DIPK1B KDR DYSF NOTCH1 AFAP1L1

5.81e-061975856a3c647af41fea923311562575a0d656fbc13cbe
ToppCellTracheal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

THSD7A DIPK1B KDR DYSF AFAP1L1

5.95e-06198585f7aa809040fa9f5782b92eec1f289d690eb5c7bd
ToppCellmetastatic_Brain-Endothelial_cells|metastatic_Brain / Location, Cell class and cell subclass

THSD7A KDR CUBN DYSF AFAP1L1

5.95e-0619858597ef7946ef11ac93318c1dd46b548dc01e5a6aba
ToppCell3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TLR4 DIPK1B KDR DYSF AFAP1L1

5.95e-0619858537d6557833877fc2ff51fbeb589e3eb832dbef5f
ToppCellTracheal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

THSD7A DIPK1B KDR DYSF AFAP1L1

5.95e-0619858577e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d
ToppCellmetastatic_Brain-Endothelial_cells-Tumor_ECs|metastatic_Brain / Location, Cell class and cell subclass

THSD7A KDR CUBN DYSF AFAP1L1

5.95e-061985855e274f29cc796dae7d64d6035e904816c25f9914
ToppCellSkin-Endothelial|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.

THSD7A DIPK1B KDR DYSF AFAP1L1

6.10e-061995856b3ef5d8f87cdfe5401d05f19339ddfcd9cda476
ToppCell3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD7A DIPK1B KDR NOTCH1 AFAP1L1

6.10e-06199585b15304d3d3f6c254969b54a61bee3d9f368840b2
ToppCell3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD7A DIPK1B KDR DYSF AFAP1L1

6.25e-06200585392abf38afc874925618397ae320a630e18b8e0a
ToppCell3'-GW_trimst-1.5-SmallIntestine-Endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD7A DIPK1B KDR DYSF AFAP1L1

6.25e-06200585fc0fd7b8e16eb593698084dca3f566d4d4bff381
ToppCell5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD7A DIPK1B KDR DYSF AFAP1L1

6.25e-0620058590061284a80d29a4ca6078f578e13d32b8cc80e1
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

THSD7A TENT5A KLHL13 SHISA8

2.50e-0513058456b9c3325e011f1dbaf9efc71bd6e1af4f96fda6
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

THSD7A TENT5A KLHL13 SHISA8

2.82e-05134584d63fff23040eada31bc35ba1e05b7c6a663e0037
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp4_Mab21l1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

THSD7A TENT5A KLHL13 SHISA6

2.99e-051365849cf076597e6fd9390850fda259daa13022f15893
ToppCell10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-MPP_myeloid|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

GLI1 KLHDC7B CUBN AFAP1L1

3.34e-05140584eb1d22f5f5dbf60b6485464baec4be9b3060f65c
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

THSD7A TENT5A SHISA6 SHISA8

3.94e-0514658447368f981180ca6a8c81a50f7f9430f12456f609
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

THSD7A TENT5A SHISA6 SHISA8

5.10e-05156584896e2d958be0a5c62fb6eebad2dfb7e1ce69f3ad
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

THSD7A TENT5A KLHL13 SHISA8

5.77e-051615843b5d7a3dab479c6959a428f3954dedd989900276
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

THSD7A TENT5A SHISA6 SHISA8

5.77e-05161584be77e99faf653480c166305df3a4e93db76f0dcb
ToppCellAdult-Immune-B_cell-D231|Adult / Lineage, Cell type, age group and donor

GLI1 BUB1B DIPK1B SHISA8

6.05e-051635844f5821299b265663c7d0352b28285f56e1988841
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WDHD1 TENT5A EML6 DCK

6.34e-051655841703d3eb644b3c743ad3c5532b1d29ea010c79c8
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

THSD7A TENT5A SHISA6 SHISA8

6.34e-05165584c6b23013d77fa9aa967b76e451c8e42b0a657c30
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

THSD7A TENT5A KLHL13 SHISA8

6.80e-05168584f3879a8e11eaf866f37c52e67021be43f0b8784a
ToppCellcellseq2-Epithelial-Epithelial_Airway-Secretory/RAS|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CYP2C9 WDHD1 AZGP1 C4BPA

7.12e-05170584b62f7184e78e9672ea88e361654f604f9df2dc5f
ToppCell3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

THSD7A DIPK1B KDR ADGRG6

7.12e-051705841a568efcff9c39b3f709b55a05d24710450a2657
ToppCell3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

THSD7A DIPK1B KDR ADGRG6

7.12e-0517058466d41d794790e621d72ac37af995510537103c9c
ToppCellcellseq2-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CYP2C9 WDHD1 AZGP1 C4BPA

7.12e-0517058400fe77bca9c28762212c498f9c49e14cb1492cca
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TENT5A KLHL13 SHISA6 SHISA8

7.28e-051715845efd15300f865ebf651e0888265cbd717bc3b9d3
ToppCell343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

CACNA1D BUB1B DIPK1B IL9R

7.28e-051715844ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc
ToppCelldroplet-Kidney-KIDNEY-1m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDX31 TENT5A TLR4 ADGRG6

7.28e-05171584d9ad6a3bce3556abd24af1630bf4a99594437c3a
ToppCell5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DIPK1B KDR DYSF AFAP1L1

7.28e-05171584b3e6e31dfe3623b960ccf692fdbd236fa4039923
ToppCellmetastatic_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass

WDHD1 KLHL21 TLR4 TOPBP1

7.28e-051715840d14bc9688c427ba2265984987dc3eea195b19eb
ToppCellFrontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Crim1_(Neuron.Gad1Gad2.Cplx3-Crim1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

ZAN CCDC168 RSPH6A

7.28e-056258391c49ae176d2a418a58398e9d5e55c77187cc2fb
ToppCellFrontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Crim1_(Neuron.Gad1Gad2.Cplx3-Crim1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

ZAN CCDC168 RSPH6A

7.28e-05625833275775572a65460b6248ee72b4c85e4d4dee424
ToppCellControl-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations)

THSD7A KDR DYSF AFAP1L1

7.45e-05172584c55dce1ed3ed7312394b4e050e1de852a994e130
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TENT5A KLHL13 SHISA6 SHISA8

7.45e-051725847e1a7700a4c2b1d100da1d6e475e73498ebb605a
ToppCell5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD7A KDR DYSF AFAP1L1

7.62e-051735847dc988fc0ba29990567bf1bcdeb3faeeee507eb1
ToppCell5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ZSWIM2 KDR DYSF AFAP1L1

7.79e-0517458442735f6a8e5ec36dd3d35aceea6d37cf3eaa1871
ToppCell3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TLR4 KDR DYSF NOTCH1

7.96e-0517558443be63976da5ad0764d24d90919a77ce46068f52
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RNLS EML6 UNC5D ADGRG6

7.96e-05175584284fdc7a9d303636a637041846850d19d114861a
ToppCell3'-GW_trimst-1-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TLR4 KDR DYSF AFAP1L1

8.51e-051785844ef6344d0ffc9c55b1240bee94b741382f1427bb
ToppCell3'-GW_trimst-1-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TLR4 KDR DYSF AFAP1L1

8.51e-05178584c65932cbedbbfacb6f0299280663fe7c88dba72b
ToppCelldroplet-Kidney-nan-21m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

THSD7A KLHL13 F12 CHRNB1

8.69e-05179584b7281160c84dd053a2981c9c76ea6cc6d2592cd5
ToppCelltumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

ZAN KLHL13 CUBN DYSF

8.69e-0517958499894067e2c2a3ed53abdc5434410c3172693496
ToppCell3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD7A KDR DYSF AFAP1L1

8.88e-0518058497e0dcb7cfbba60a782824c5e23995058609fcd4
ToppCell367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells)

THSD7A KDR DYSF AFAP1L1

9.07e-05181584b244ecaa442bbef51289d8ec574ef08fa9e96318
ToppCell5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DIPK1B KDR GABBR2 AFAP1L1

9.07e-051815849bfd93cf053beaee806cacdffd7abef02f94aec6
ToppCell367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells)

THSD7A KDR DYSF AFAP1L1

9.07e-05181584dd79de8098edb385a0f85d0e9621503cdf76ec43
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DIPK1B KDR DYSF AFAP1L1

9.07e-051815842c660fcf0404c155955b67ab2958d6e6b0e30024
ToppCellPND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

KLHL21 PRMT9 CHRNB1 AFAP1L1

9.47e-051835843ef9ac1ae13b6172f9121ab1c129ecaa0fef460f
ToppCelldroplet-Trachea-nan-3m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KDR DYSF NOTCH1 AFAP1L1

9.67e-05184584fa5c3020e75fdde1363393dea97ebd99f1eae9ff
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZAN UNC5D OTOG DNAH1

9.67e-051845842cbed6462fea2622871bb7e49b0df3d984239281
ToppCelldroplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

THSD7A KLHL13 CUBN ADGRG6

9.67e-05184584087666ba949b129c53d7ace40f9e543e3875a7de
ToppCelldroplet-Trachea-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KDR DYSF NOTCH1 AFAP1L1

9.67e-05184584ad520ab6bb776b5303df505b7e1afb22484f18a7
ToppCell5'-GW_trimst-2-LymphNode-Endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DIPK1B KDR DYSF AFAP1L1

9.67e-05184584df2d42e1eae29fa0a1ed9e389c95b38952b46892
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CYP2C9 THSD7A C4BPA DYSF

9.67e-051845847ecdf2645e9378cf2f5ce4557f2cf100e6f184ba
ToppCell5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DIPK1B KDR DYSF AFAP1L1

9.67e-051845841ace70f12b417185bdd46042833f72b3b6815966
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZAN UNC5D OTOG DNAH1

9.67e-05184584ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZAN UNC5D OTOG DNAH1

9.67e-051845842b19a8c5f823e00812908b23e66bb4e563278aff
ToppCelldroplet-Trachea-nan-3m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KDR DYSF NOTCH1 AFAP1L1

9.67e-051845841d63cb75a89c5f3f3b9ebf7fce8cb0fd4a92b645
ToppCelldroplet-Trachea-nan-3m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KDR DYSF NOTCH1 AFAP1L1

9.67e-0518458476caad53d55fff5acca27bf190a6de7b27437d9f
ToppCelldroplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KDR DYSF NOTCH1 AFAP1L1

9.67e-051845841fc1f0a3b4dbb085ebcc3960f67be24a108fe5b9
ToppCelldroplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KDR DYSF NOTCH1 AFAP1L1

9.67e-051845842467207aaea307873ab286f89cfc7668a227a694
ToppCellfacs-Trachea-nan-24m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KDR DYSF NOTCH1 AFAP1L1

9.87e-05185584dec60254204014083ff3b4aec0cc75410950a486
ToppCell3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TLR4 KDR DYSF AFAP1L1

9.87e-05185584fb84fcf7f51f53489bcb3962fa9cb483e48257ed
ToppCell3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD7A DIPK1B KDR AFAP1L1

9.87e-05185584602536a3308a848f106adcb0a83530997440c8f4
ToppCellEndothelial-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id

THSD7A KDR DYSF ADGRG6

9.87e-05185584dee0b7ba2f338f0979d2306aedf52ac35a36b60c
ToppCellfacs-Trachea-nan-24m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KDR DYSF NOTCH1 AFAP1L1

9.87e-05185584201465dc0d7aa0336a36d37805cae1155a5adfe1
ToppCellfacs-Trachea-nan-24m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KDR DYSF NOTCH1 AFAP1L1

9.87e-05185584334f006c3ef33338ff8d649309d3f448733a3a99
ToppCell3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TLR4 KDR DYSF AFAP1L1

1.01e-041865849d250d5ae7cf9129be05b41d70cb6c3a046c5f1e
ToppCell3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DIPK1B KDR DYSF AFAP1L1

1.03e-0418758450d5730e2cd4951d3ad0641fc81ae9f6ddabafe7
ToppCell3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD7A KDR DYSF AFAP1L1

1.03e-041875840ef82111b9049cc7ee78d64d240e1f10ab14d6b6
ToppCell5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DIPK1B KDR DYSF AFAP1L1

1.03e-04187584d9d10ed7c905778a29a0dc3ced3eef02a6b1de5c
ToppCellwk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

DIPK1B KDR NOTCH1 AFAP1L1

1.05e-04188584366a2d59b9c81d8a7659749f9c07efa46b49a39a
ToppCellfacs-Trachea-3m-Endothelial-endothelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KDR DYSF NOTCH1 AFAP1L1

1.05e-0418858420072a2a3f9ecbe727c850629f19420cf60e4bc5
ToppCellfacs-Trachea-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KDR DYSF NOTCH1 AFAP1L1

1.05e-04188584dd817059e1b4225e84733559f7839cc973b7dfd6
ToppCell5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KDR DYSF NOTCH1 AFAP1L1

1.05e-04188584524a12f433c7b6f33fad36c0716afa06cd3235e9
ToppCellfacs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KDR DYSF NOTCH1 AFAP1L1

1.05e-041885846ab5ce8569f896a0fe7a76b8b4a83661e5499b8c
ToppCell5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KDR DYSF NOTCH1 AFAP1L1

1.05e-04188584d2610b81b3c7f22977b5e2137b1f61410fc4ef16
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

THSD7A KDR DYSF AFAP1L1

1.05e-041885842db80767903703e7e0a1a37c598f7877a909ee94
ToppCellfacs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KDR DYSF NOTCH1 AFAP1L1

1.07e-04189584ecbe079606406f47d4fc97fe1670790dda8e10de
ToppCell5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DIPK1B KDR DYSF AFAP1L1

1.07e-041895849e58411e51019ca59e78d3e737d65d2bcbbea2be
DrugItraconazole

CYP2C19 CYP2C9 GLI1 KDR

1.20e-0632574ctd:D017964
Drugdibenzylfluorescein

CYP2C19 CYP2C9

6.16e-062572ctd:C558664
Drugpantoprazole

CYP2C19 CYP2C9 C4BPA

1.40e-0519573ctd:C064276
Drugclevidipine

CACNA1D CYP2C19 CYP2C9

1.65e-0520573CID000153994
Drugpicoxystrobin

CYP2C19 CYP2C9

1.84e-053572ctd:C556557
Drug2-hydroxychlorpropamide

CYP2C19 CYP2C9

1.84e-053572CID003082454
Drugmono-N-demethyladinazolam

CYP2C19 CYP2C9

1.84e-053572ctd:C050132
DrugDelavirdine

CYP2C19 CYP2C9

1.84e-053572ctd:D020008
DrugYM-09730-5

CACNA1D CYP2C19 CYP2C9

2.54e-0523573CID000002296
DrugNSC308876

CYP2C19 CYP2C9 GBA2

2.90e-0524573CID000432447
Drug1-(6-((2-(dimethylamino)ethyl)(methyl)amino)-1,3-dimethyl-1H-pyrazolo(3,4-b)pyridine-5-carbonyl)-3-(3-isopropoxyphenyl)urea

CYP2C19 CYP2C9

3.68e-054572ctd:C558737
Drug7,8-dihydromethysticin

CYP2C19 CYP2C9

3.68e-054572ctd:C107882
Drugmethysticin

CYP2C19 CYP2C9

3.68e-054572ctd:C076881
Drugrabeprazole-thioether

CYP2C19 CYP2C9

3.68e-054572ctd:C523099
Drugbupropion

CYP2C19 CYP2C9 RNLS CHRNB1

5.09e-0581574CID000000444
Drugnorselegiline

CYP2C19 CYP2C9 RNLS

5.19e-0529573CID000185859
Drugbufuralol

CYP2C19 CYP2C9

6.13e-055572ctd:C010831
Drug2-oxo-clopidogrel

CYP2C19 CYP2C9

6.13e-055572ctd:C540904
Drugbenfuracarb

CYP2C19 CYP2C9

6.13e-055572ctd:C096128
Drugmono(2-ethyl-5-hydroxyhexyl) phthalate

CYP2C19 CYP2C9

6.13e-055572ctd:C479069
DrugM3/M4

CYP2C19 CYP2C9 CHRNB1

7.01e-0532573CID000486507
Drugtemazepam

CYP2C19 CYP2C9 GABBR2

8.42e-0534573CID000005391
Drug4,4'-cyclohexylidenebisphenol

CYP2C19 CYP2C9

9.18e-056572ctd:C570106
Drug4',5-dihydroxydiclofenac

CYP2C19 CYP2C9

9.18e-056572CID003052567
Drugavasimibe

CYP2C19 CYP2C9

9.18e-056572ctd:C423185
Drugdiniconazole

CYP2C19 KDR

9.18e-056572ctd:C049346
Drugmono(2-ethyl-5-oxohexyl)phthalate

CYP2C19 CYP2C9

9.18e-056572ctd:C080276
Drug4'-hydroxyflurbiprofen

CYP2C19 CYP2C9

9.18e-056572CID000157678
DrugAC1O5Z5L

CYP2C19 CYP2C9

9.18e-056572CID006443527
Drugmepirodipine

CYP2C19 CYP2C9

9.18e-056572ctd:C050699
DrugCyclodextrins

CYP2C19 CYP2C9

9.18e-056572ctd:D003505
Drug3'-hydroxydiclofenac

CYP2C19 CYP2C9

9.18e-056572CID000112230
DrugIndoles

CYP2C19 KDR DYSF

1.28e-0439573ctd:D007211
Drugsulprofos

CYP2C19 CYP2C9

1.28e-047572CID000037125
Drug5-n-butyl-pyrazolo(1,5-a)pyrimidine

CYP2C19 CYP2C9

1.28e-047572ctd:C547858
Drug5-fluorotryptamine

CYP2C19 CYP2C9

1.28e-047572ctd:C034536
Drugdesmethyltrimipramine

CYP2C19 CYP2C9

1.28e-047572CID000160632
Drugquinidine-N-oxide

CYP2C19 CYP2C9

1.28e-047572CID000050979
Drug12-hydroxyellipticine

CYP2C19 CYP2C9

1.28e-047572ctd:C517214
Drug6-Fluoro-6-desoxyoxymorphone

CYP2C19 CYP2C9

1.28e-047572CID005486899
Drug16-O-demethylaconitine

CYP2C19 CYP2C9

1.28e-047572ctd:C486136
DrugVoriconazole

CYP2C19 CYP2C9

1.28e-047572ctd:D065819
DrugParoxetine maleate [64006-44-6]; Up 200; 1uM; PC3; HT_HG-U133A

CACNA1D AZGP1 TLR4 C4BPA CUBN

1.37e-041985754556_UP
Drugdoxepin

CYP2C19 CYP2C9 RNLS

1.38e-0440573CID000003158
Drugmidazolam

CYP2C19 CYP2C9 GABBR2 CHRNB1

1.50e-04107574CID000004192
Drug13-hydroxyeicosatetraenoic acid

CYP2C19 CYP2C9

1.71e-048572CID006439499
Drug5-fluoro-alpha-methyltryptamine

CYP2C19 CYP2C9

1.71e-048572ctd:C051101
Drug5-methyltryptamine

CYP2C19 CYP2C9

1.71e-048572ctd:C027552
DrugAC1L4AGK

CYP2C19 CYP2C9

1.71e-048572CID000182186
Drug11-HODE

CYP2C19 CYP2C9

1.71e-048572CID006438497
Drug5-bromotryptamine

CYP2C19 CYP2C9

1.71e-048572ctd:C040997
Drug4-hydroxyalprazolam

CYP2C19 CYP2C9

1.71e-048572CID000182017
Drugsulforidazine

CYP2C19 CYP2C9

1.71e-048572CID000031765
Drugdesmethylmaprotiline

CYP2C19 CYP2C9

1.71e-048572CID000119409
Druggermacrone

CYP2C19 CYP2C9

1.71e-048572ctd:C048393
Drug11 beta-hydroxytestosterone

CYP2C19 CYP2C9

1.71e-048572CID000114920
Drug7-methyltryptamine

CYP2C19 CYP2C9

1.71e-048572ctd:C036696
Drug1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid

CYP2C19 CYP2C9

1.71e-048572ctd:C585955
Drugnefazodone

CYP2C19 CYP2C9 RNLS

1.71e-0443573CID000004449
Drug1,2,3-triazole

CYP2C19 CYP2C9 RNLS

1.96e-0445573CID000067516
Drugdihydromethysticin

CYP2C19 CYP2C9 OGDH

2.09e-0446573CID000088308
Drug4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide

CYP2C19 CYP2C9

2.19e-049572ctd:C545880
Drugcis-linoleic acid

CYP2C19 CYP2C9

2.19e-049572CID006431005
DrugFluorescein

CYP2C19 CYP2C9

2.19e-049572ctd:D019793
DrugAC1L8U1Y

CYP2C19 CYP2C9

2.19e-049572CID000408120
DrugAcenocoumarol

CYP2C19 CYP2C9

2.19e-049572ctd:D000074
Drug5-chlorotryptamine

CYP2C19 CYP2C9

2.19e-049572ctd:C529169
Drug3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate

CYP2C19 CYP2C9

2.19e-049572ctd:C109602
Drug2-nitroanisole

CYP2C19 CYP2C9

2.19e-049572ctd:C005328
Drug5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid

CYP2C19 CYP2C9

2.19e-049572ctd:C000588958
DrugTryptamines

CYP2C19 CYP2C9

2.19e-049572ctd:D014363
Drugphenylcyclopropane

CYP2C19 CYP2C9

2.19e-049572CID000070112
Drugcitalopram

CACNA1D CYP2C19 CYP2C9 RNLS

2.34e-04120574CID000002771
DrugKW-3049

CACNA1D CYP2C19 CYP2C9

2.68e-0450573CID000002324
DrugCelsior

CYP2C19 CYP2C9

2.74e-0410572ctd:C088453
DrugNmiQ

RNLS OGDH

2.74e-0410572CID000019850
DrugNSC-169892

RNLS F12

2.74e-0410572CID000043479
DrugMephenytoin

CYP2C19 CYP2C9

2.74e-0410572ctd:D008617
Drugsulconazole

CYP2C19 CYP2C9

2.74e-0410572CID000005318
Drug13-hydroxyellipticine

CYP2C19 CYP2C9

2.74e-0410572ctd:C517215
Drug3-hydroxyflunitrazepam

CYP2C19 CYP2C9

2.74e-0410572CID000128908
DrugAHMA

CYP2C19 CYP2C9

2.74e-0410572CID000216240
DrugS)-3-phenylpiperidine

CYP2C19 CYP2C9

2.74e-0410572CID000101021
Drug8-hydroxydaidzein

CYP2C19 CYP2C9

2.74e-0410572CID005466139
DrugMelarsoprol

CYP2C19 CYP2C9

2.74e-0410572ctd:D008549
Drugsitaxsentan

CYP2C19 CYP2C9

2.74e-0410572ctd:C106276
Drugnorketobemidone

CYP2C19 CYP2C9

2.74e-0410572CID000161154
Drug8-hydroxycarteolol

CYP2C19 CYP2C9

3.34e-0411572CID000124688
DrugHaloperidol metabolite I

CYP2C19 CYP2C9

3.34e-0411572CID000038282
DrugAC1L2H09

CYP2C19 CYP2C9

3.34e-0411572CID000020797
DrugC23:0

TLR4 F12

3.34e-0411572CID000017085
Drugtrans-1,2-dihydro-1,2-naphthalenediol

CYP2C19 CYP2C9

3.34e-0411572ctd:C507866
DrugAC1MHYLG

TLR4 F12

3.34e-0411572CID003035009
Drugtriazolam

CYP2C19 CYP2C9 GABBR2

3.37e-0454573CID000005556
Drugmirtazapine

CYP2C19 CYP2C9 RNLS

3.37e-0454573CID000004205
Drug3-demethylcolchicine

CYP2C19 CYP2C9

4.00e-0412572CID000299664
Drug4-(N-propionylanilino)piperidine

CYP2C19 CYP2C9

4.00e-0412572CID000259381
Drug5-hydroxydiclofenac

CYP2C19 CYP2C9

4.00e-0412572CID003052566
Drugcarveol

CYP2C19 CYP2C9

4.00e-0412572CID000007438
Drugdesethylamodiaquine

CYP2C19 CYP2C9

4.00e-0412572ctd:C047386
DiseaseX-21258 measurement

CYP2C19 CYP2C9

1.10e-053572EFO_0800802
Diseaseinvasive aspergillosis (is_implicated_in)

CYP2C19 TLR4

2.19e-054572DOID:0050073 (is_implicated_in)
Diseasehemangiopericytoma (is_marker_for)

KDR NOTCH1

1.31e-049572DOID:264 (is_marker_for)
Diseasetype 2 diabetes mellitus (is_marker_for)

CACNA1D TLR4 KDR F12

1.41e-04136574DOID:9352 (is_marker_for)
Diseasealpha wave measurement, electroencephalogram measurement

NOX3 DNAH1

1.63e-0410572EFO_0004357, EFO_0006870
DiseaseX-11308 measurement

CYP2C19 CYP2C9

1.99e-0411572EFO_0800693
Diseaseretinopathy of prematurity (biomarker_via_orthology)

KDR NOTCH1

2.39e-0412572DOID:13025 (biomarker_via_orthology)
Diseasethymol sulfate measurement

CYP2C19 CYP2C9

2.39e-0412572EFO_0021170
Diseaseliver cirrhosis (is_marker_for)

AZGP1 TLR4 KDR

5.43e-0482573DOID:5082 (is_marker_for)
Diseasemyocardial infarction (is_implicated_in)

TLR4 KDR F12

9.40e-0499573DOID:5844 (is_implicated_in)
DiseaseAcute Kidney Insufficiency

CYP2C19 CYP2C9 TLR4

9.96e-04101573C1565662
DiseaseAcute kidney injury

CYP2C19 CYP2C9 TLR4

9.96e-04101573C2609414
DiseaseKidney Failure, Acute

CYP2C19 CYP2C9 TLR4

9.96e-04101573C0022660
Diseasemacular degeneration (is_implicated_in)

TLR4 KDR

1.25e-0327572DOID:4448 (is_implicated_in)
DiseaseMajor Depressive Disorder

CYP2C19 CYP2C9 KDR GABBR2

1.26e-03243574C1269683
Diseasechronic kidney disease (biomarker_via_orthology)

RNLS AZGP1

1.34e-0328572DOID:784 (biomarker_via_orthology)
Diseaseglutamate measurement

UNC5D OTOG

1.44e-0329572EFO_0010487
Diseasediabetes mellitus (is_implicated_in)

CYP2C9 TLR4

1.44e-0329572DOID:9351 (is_implicated_in)
Diseaseresponse to angiotensin receptor blocker

CACNA1D EML6

1.54e-0330572EFO_0010735
DiseaseUnipolar Depression

CYP2C19 CYP2C9 KDR GABBR2

1.59e-03259574C0041696
Diseasehypertension (is_implicated_in)

CYP2C9 RNLS KDR

1.67e-03121573DOID:10763 (is_implicated_in)
DiseaseAbnormality of refraction

CACNA1D DNAJC13 THSD7A RNLS TENT5A SHISA6

1.86e-03673576HP_0000539
Diseaseasthma (is_marker_for)

TLR4 KDR IL9R

1.88e-03126573DOID:2841 (is_marker_for)

Protein segments in the cluster

PeptideGeneStartEntry
NPTQSPWCSQYRRQL

BUB1B

716

O60566
TPVSRWIYPQQDCQT

BAG4

181

O95429
QSITCSGNRTWYPEV

C4BPA

521

P04003
PSEETCWEQAVYPVQ

PRMT9

426

Q6P2P2
YCPQENALWPNLTVR

ABCA9

1366

Q8IUA7
NPLVTYWGPVDISNC

ADGRG6

566

Q86SQ4
WQPPGIYRSSCSIQV

CHRNB1

141

P11230
WRTCLSVAPGQQVYS

DIPK1B

91

Q5VUD6
TVVQTYNAGRPVWSC

RFWD3

531

Q6PCD5
QKYPNCPTDVRQWAT

ORC4

416

O43929
TSQSWQPQTYQICLV

RAB3GAP2

511

Q9H2M9
VNTYNCRCPPEWTGQ

NOTCH1

276

P46531
TPTERIYWANLSQCP

LEXM

291

Q3ZCV2
CRVQLVTYQPDWPAA

FRMD8P1

176

Q9BZ68
CPQQASYPDPTQETW

GLI1

766

P08151
PEIWTLTYQQNSATP

ELP1

1271

O95163
QVTWIVQYNAPSSPA

DDX31

596

Q9H8H2
LWPNQAPYTVCNSSL

OGDH

706

Q02218
DIYPPNVECVWNIVS

CUBN

1756

O60494
VTTEGRPPLQVCQYW

DNAH1

341

Q9P2D7
PTVECYNPRTNEWTY

KLHL13

456

Q9P2N7
LVTVDCYNPQTGQWR

KLHL21

301

Q9UJP4
RIVSTPWIQICNNFP

CYP2C19

206

P33261
PWIQICNNFPTIIDY

CYP2C19

211

P33261
WTVYQLPGQNVTLTC

GBA2

236

Q9HCG7
QCWRQTYSESVPVIA

CEP120

571

Q8N960
TNQWPYGDICSISPV

DNAJC13

46

O75165
NPQLQWNTTEPSRTC

GABBR2

861

O75899
FCYNPLTNIWSQVRP

KLHDC7B

376

Q96G42
SCQFWKNPEVSRPYV

KLF18

951

A0A0U1RQI7
VPEPVARWCNVQSTQ

DCK

51

P27707
ISWDPYQPNRVVSCG

EML6

156

Q6ZMW3
QELCVSGTIWSYPNP

CCDC168

2761

Q8NDH2
PWIQICNNFSPIIDY

CYP2C9

211

P11712
PQTYCVSGPNQWRDQ

DYSF

1681

O75923
RDWTPCYTPLIQVEQ

CACNA1D

1991

Q01668
NATWVPYTVQEPTDC

OTOG

2906

Q6ZRI0
APCQPWASEATYRNV

F12

236

P00748
CPQYSVAVVRSNLWP

RSPH6A

616

Q9H0K4
RQVISVPIWPFQCYN

TRIM34

321

Q9BYJ4
RRCQLVPWSVQQDSP

THSD7A

841

Q9UPZ6
QCTNYQSPVWVQTPS

SHISA6

141

Q6ZSJ9
CSNYDTPAWVQTGRP

SHISA8

106

B8ZZ34
SEWSQPVCFQAPQRQ

IL9R

246

Q01113
YAEWQTVAQCPVPQF

NOX3

246

Q9HBY0
EQCLQRYSWPSVKPQ

SUPT20HL2

236

P0C7V6
PPNSTERYTRWINQL

B3GNTL1

146

Q67FW5
SCQNQWPEPRVYDDV

AFAP1L1

546

Q8TED9
IDVPWAGQYITSNPC

RNLS

206

Q5VYX0
QTLNIVTWSPCGQYL

WDHD1

231

O75717
QEVPFSRVWCSNRQP

UNC5D

771

Q6UXZ4
APAYWRPNSQILSCN

ZFYVE1

591

Q9HBF4
SCPIDGQVIYNPLTW

ZSWIM2

381

Q8NEG5
TYQSWVVVAVPPQDT

AZGP1

261

P25311
SDNPQTVFPRYCVSW

STARD7

291

Q9NQZ5
SQAVSVTNPYPCEEW

KDR

471

P35968
PVFTCQQQTYSTWLP

TENT5A

426

Q96IP4
WEPCVEVVPNITYQC

TLR4

26

O00206
RLASNLQWPSCPTQY

TOPBP1

1156

Q92547
LQWPSCPTQYSELQV

TOPBP1

1161

Q92547
SQRPYWQNTSVTVPS

ZAN

486

Q9Y493